Ads
related to: Psoriatic Arthritis Medicine- Scalp Psoriasis Results
View Clinical Trial Information For
a Scalp Psoriasis Therapy Option.
- Clinical Studies
Review Clinical Trial Results for
a Plaque Psoriasis Treatment.
- Safety & Prescribing Info
View Safety & Prescription Info for
a Plaque Psoriasis Treatment.
- Safety & Risk Factor Info
View Metabolic Syndrome Risk Info
For a Psoriasis Treatment Option.
- Important HCP Information
See Psoriasis Treatment Options To
Help Your Patients Find Relief.
- Biologic MOA for PsO
Learn More About the MOA for this
Plaque Psoriasis Treatment.
- Scalp Psoriasis Results
Search results
A New Psychotherapeutic 'Gold Standard' for Chronic Pain?
Medscape· 1 day agoA single course of treatment with emotional awareness and expression therapy (EAET) was associated...
Alvotech (NASDAQ:ALVO) Short Interest Update
ETF DAILY NEWS· 6 days agoAlvotech (NASDAQ:ALVO – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 93,900 shares, a drop ...
Johnson & Johnson (NYSE:JNJ) Trading Up 0.3%
ETF DAILY NEWS· 21 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report) traded up 0.3% during mid-day trading on Monday . Morgan Stanley dropped their target price on Johnson & Johnson from $168.00 to $167.00 and set ...
Brown Shipley& Co Ltd Sells 1,579 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoBrown Shipley& Co Ltd reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 46.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Buckingham Strategic Partners LLC Has $2.22 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoBuckingham Strategic Partners LLC lessened its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 45.6% in the fourth quarter, according to the company in its most recent 13F filing with ...
Johnson & Johnson (NYSE:JNJ) Position Trimmed by Auxier Asset Management
ETF DAILY NEWS· 5 days agoAuxier Asset Management decreased its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.0% in the fourth quarter, according to its most recent 13F filing with the SEC. Johnson & Johnson ...
Johnson & Johnson (NYSE:JNJ) Given Outperform Rating at Royal Bank of Canada
ETF DAILY NEWS· 2 days agoRoyal Bank of Canada reaffirmed their outperform rating on shares of Johnson & Johnson (NYSE:JNJ – Free Report) in a research note released on Monday morning, Benzinga reports. The brokerage ...
Newbridge Financial Services Group Inc. Sells 400 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 18 hours agoNewbridge Financial Services Group Inc. lessened its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 7.4% in the 4th quarter, according to the company in its most recent 13F filing with ...
Burkett Financial Services LLC Sells 122 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 18 hours agoBurkett Financial Services LLC decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.1% in the first quarter, according to the company in its most recent 13F filing ...
Appleton Partners Inc. MA Sells 3,030 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 21 hours agoAppleton Partners Inc. MA decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The ...
Ads
related to: Psoriatic Arthritis Medicine